💼 About This Role

You'll lead the Phase 3 program for a high-priority immunology therapy, KT-621, overseeing clinical operations from strategy through regulatory approval. Your core impact is driving cross-functional execution while building and managing a world-class operations team. This role offers the chance to shape a pipeline at the forefront of targeted protein degradation.

🎯 What You'll Do

• Lead strategic planning and execution of late-stage clinical trials
• Develop program project plans including budgets and timelines
• Collaborate cross-functionally with Clinical Development and Regulatory
• Oversee CROs and vendors to ensure adherence to contracts and quality

📋 Requirements

• 12+ years in clinical operations within pharma or biotech
• Experience building and leading a high-performing clinical operations team
• Expertise in global regulatory and compliance requirements (ICH GCP)

✨ Nice to Have

• BA/BS in health-related field
• Prior experience overseeing Phase 3 programs

🎁 Benefits & Perks

• 💰 Competitive base salary with annual bonus and equity
• 🏖️ Comprehensive benefits package
• 🏢 Inclusive and collaborative culture

📨 Hiring Process

Estimated timeline: 3-5 weeks · AI estimate

1. 1Recruiter Screen· 30 min
2. 2Hiring Manager Interview· 45 min
3. 3Panel Interview· 60 min